What does CUSIP 82835W108 represent in this 13F holders report?

CUSIP 82835W108 is the security identifier for SPRY - ARS Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held SPRY - ARS Pharmaceuticals, Inc. - Common Stock in Q3 2025?

187 institutional investors reported SPRY - ARS Pharmaceuticals, Inc. - Common Stock for Q3 2025. Use the holders table for investor-level position and value details.

ARS Pharmaceuticals, Inc. - Common Stock (SPRY)

CUSIP: 82835W108

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class: Equity / Common Stock
Total 13F shares: 83,632,743
Total 13F value: $840,434,931
Share change: -894,930
Put/Call ratio: 57%
SEC-reported price per share: $10.05
Number of holders: 187
Value change: -$93,311,095
Number of buys: 111
Number of sells: 85
Shares outstanding: 98,457,811

Security key

82835W108

Report period

Q3 2025

Institutions

187

Top holders

SPRY full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 ARS Pharmaceuticals, Inc. SEC filings ARS Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 82835W108

Newer quarter: Q2 2026

Recent filing periods:

Q2 2026

Ownership snapshot

Top reported holders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

15/15

Latest evidence

30 Jun 2025

13F 13D/G 3/4/5 Lead comparable stake: 11% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 5

RA CAPITAL MANAGEMENT, L.P. 11%

James E. Flynn 7.8%

DEERFIELD MANAGEMENT COMPANY, L.P. 9.9%

ORBIMED ADVISORS LLC 8.4%

BlackRock, Inc. 4.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	13F 13D/G Company 13F 13D/G	11% from 13D/G	$189,524,049 10,860,977 shares	—	30 Jun 2025
James E. Flynn	3/4/5 13D/G 10%+ Owner · Deerfield Management Company, L.P. 3/4/5 13D/G	7.8% from 13D/G	$180,437,416 9,774,508 shares	—	27 Jun 2025
DEERFIELD MANAGEMENT COMPANY, L.P.	13F Company 13F	9.9%	$169,692,665 9,724,508 shares	—	30 Jun 2025
ORBIMED ADVISORS LLC	13F Company 13F	8.4%	$144,634,500 8,288,510 shares	—	30 Jun 2025
BlackRock, Inc.	13F Company 13F	4.5%	$77,189,447 4,423,464 shares	—	30 Jun 2025
SR ONE CAPITAL MANAGEMENT, LP	13F Company 13F	4.1%	$70,025,157 4,012,903 shares	—	30 Jun 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

187

83,632,743

Rows available

187

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

185

Q3 2025 holders

187

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 value	Q3 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend